Research news

A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.

Six COVID-19 vaccines are safe and boost immunity for people who have had two doses of AstraZeneca or Pfizer-BioNTech, results from the UK-wide COV-BOOST trial show.

Professor Charles Swanton is one of three innovative cancer investigators to be awarded the prestigious Paul Marks Prize for Cancer Research by the Memorial Sloan Kettering Cancer Center (MSK).

An antibody treatment trialled at UCLH cuts the risk of developing symptomatic COVID-19 by 77%.